Laura Hamill
Direktor/Vorstandsmitglied bei Y-MABS THERAPEUTICS, INC.
Vermögen: 193 121 $ am 30.04.2024
Aktive Positionen von Laura Hamill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2020 | - |
| Independent Dir/Board Member | 01.04.2020 | - | |
| BB BIOTECH AG | Direktor/Vorstandsmitglied | 17.03.2022 | - |
| Women Business Leaders of the US Health Care Industry Fnd | Corporate Officer/Principal | - | - |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Direktor/Vorstandsmitglied | 09.02.2022 | - |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | - | - |
Unchained Labs LLC
 Unchained Labs LLC BiotechnologyHealth Technology Unchained Labs LLC is a private company that provides problem-solving products to biologics and gene therapy researchers. The company is based in Pleasanton, CA. The company's aim is to help researchers break free from tools that are not effective. The company was founded in 2015 by Timothy A. Harkness, who has been the CEO since 2015. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Laura Hamill
Ehemalige bekannte Positionen von Laura Hamill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SCILEX HOLDING COMPANY | Direktor/Vorstandsmitglied | 09.11.2022 | 21.09.2023 |
| Independent Dir/Board Member | 09.11.2022 | 21.09.2023 | |
| PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.08.2021 | 30.08.2023 |
| Independent Dir/Board Member | 01.08.2021 | 30.08.2023 | |
| ANAPTYSBIO, INC. | Direktor/Vorstandsmitglied | 24.09.2019 | 01.04.2023 |
| Independent Dir/Board Member | 24.09.2019 | 01.04.2023 | |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Laura Hamill
| University of Arizona | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 15 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 10 |
| Independent Dir/Board Member | 6 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| BB BIOTECH AG | Finance |
| SCILEX HOLDING COMPANY | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Women Business Leaders of the US Health Care Industry Fnd | |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
Unchained Labs
Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Health Technology |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Hamill Advisory Group LLC | |
Unchained Labs LLC
Unchained Labs LLC BiotechnologyHealth Technology Unchained Labs LLC is a private company that provides problem-solving products to biologics and gene therapy researchers. The company is based in Pleasanton, CA. The company's aim is to help researchers break free from tools that are not effective. The company was founded in 2015 by Timothy A. Harkness, who has been the CEO since 2015. | Health Technology |
- Börse
- Insiders
- Laura Hamill
- Erfahrung
